DESC^Proportion and Incidence Rates for Treatment-Emergent Herpes Simplex (CMQ) - Short-Term Safety Pool
RPTTYPE^ADAE
TABNO^Table STSP.14.3.1.4.2
RPTGRAPH^NO
KANJI^NO
APPDX^
SECT^
ITEM^
TABNUM^STSP.14.3.1.4.2
PAGESTYL^LANDSCAPE
SOURCEDA^ADTTEAE
INPUTDA^ADTTEAE
G_ADSL_DSIN^DATVPROT.ADSL
G_ADSL_SUBSET^SAFFL EQ 'Y'
G_A_DPTVAR^AVAL
G_A_DSIN^DATVPROT.ADTTEAE
G_A_SLABEL^
G_A_STAT^
G_A_SUBSET^PARAMN=1026
G_D_BYHEAD^
G_D_BYLENGTHS^ 
G_D_ODS_ROWJUST^
G_D_ODS_STATJUST^
G_D_PAGEBYN^0
G_D_ROWHEAD^
G_D_ROWLENGTH^70
G_D_STATHEAD^BLANK
G_D_STATLENGTH^35
G_FMTGEN^
G_R_TPMAX^
G_S_BYVAR^
G_S_NDISPYN^N
G_S_NSUBGRPDISPYN^
G_S_SUBGRPLABEL^ 
G_S_SUBGRPTOTLABEL^
G_S_SUBGRPTOTYN^
G_S_SUBGRPVAR^ 
G_S_TOTALYN^
G_S_TOTLABEL^
G_S_TRTTXT^TRTA
G_S_TRTVAR^TRTAN
G_TREATMAPGEN^1:|Placebo\2:Abrocitinib|100mg QD\3:Abrocitinib|200mg QD\2+3:All|Abrocitinib
_MLOGIC^Y
_MPRINT^Y
_SYMBOLGEN^Y
TITLE1^&tabno
TITLE2^&protx
TITLE3^&desc
TITLE4^ 
TITLE5^ 
TITLE6^ 
TITLE7^ 
TITLE8^
TITLE9^
TITLE10^
FOOT1^&pas.
FOOT2^&rp.
FOOT3^&py.
FOOT4^&abbrhr.
FOOT5^&ci
FOOT6^&model.
FOOT7^
FOOT8^
FOOT9^
DRVRNAME^adae_hr_ir.sasdrvr
DEPEND^$(DATVPROT)adtteae.$(SSD01)
REPREV^$Revision: 1.1 $ $Date: 2022/09/01 17:00:30 $
